Introduction
Three enzyme deficiencies have been described in association with galactose disorders: galactose-1-phosphate uridyl transferase (EC 2.7.1.12) (clas sical galactosemia), galactokinase (EC 2.7.1.6) and galactose-4-epimerase (EC 5.1.3.2) (Segal, 1995) . The first enzyme catalyses the formation of uridyldiphosphate (UDP)-galactose (Gal) and glucosel-phosphate (Glu-l-P) from galactose-l-phosphate (Gal-l-P) and UDP-glucose. As a conse quence of this block in the sugar nucleotide path way, Gal-l-P accumulates in the lens, liver, kidney and brain (Waggoner et al., 1990) , whereas Gal ac cumulates in liver, brain and kidney. Galactitol (dulcitol) (Galtol), the sugar alcohol of Gal also accumulates in brain and lens because of the ac tion of aldol reductase on Gal (Wells et al., 1965) . The cataracts, so common in this disorder, appear to be the result of intralenticular accumulation of Galtol (Schweitzer, 1995; Segal, 1995) . Gal-l-P is believed to play a toxic role resulting in the gener ation of liver and cerebral dysfunction (Segal, 1995) . The infant with deficiency of Gal-l-P uridyl transferase presents a severe clinical picture. The patients develop diarrhea, vomiting, dehydration, hyperbilirubinemia, hepatic dysfunction, prolon gation of clotting times and they are at risk in de veloping severe mental retardation and seizures (Schulpis et al., 1997) . Renal aminoaciduria, pro teinuria and renal tubular acidosis are also some of the symptoms.
One avenue of support of this view comes from patients with galactokinase deficiency galac tosemia in whom no Gal-l-P accumulates, where Galtol buildup cataracts and increases of intracer ebral osmolarity (Segal, 1995; Schulpis et al., 1997) . Feeding Gal to rats there was demonstrated a diminished responsiveness of synaptic endings to acetylcholine (ACh) (Berry et al., 1981) . Further more, acetylcholinesterase (AChE, EC 3.1.1.7) at nerve endings represents the molecular target of organophosphorus esters (OP) and carbamate tox icity. When the enzyme is blocked, it can no longer participate in the hydrolysis of ACh. Thus ACh action is enhanced and due to the widespread dis tribution of cholinergic functions, toxic effects in volve the parasympathetic, motor and central ner vous system (Sussman et al., 1999) .
The objective of this study was the evaluation of AChE activity in the rat brain homogenates in relation to various concentrations of Gal and its derivatives.
Materials and M ethods

A nim als
For the experiments conducted on homogenised rat brain, 21 day old Albino Wistar rats of both sexes (Saint Savvas Hospital, Athens, Greece) were used. The suckling rats with their mother were housed in a cage at constant room temper ature (22± °C) under a 12hL:12hD (light 08.00-20.00 h) cycle. Animals were cared for in accor dance with the principles of the "Guide to the Care and Use o f Experimental A nim als " (Committee on Care and Use of Laboratory Animals, 1985) .
Tissue preparation
Rats were sacrificed by decapitation. Whole brains from five rats were rapidly removed, weighed and thoroughly washed with isotonic sa line. They were homogenized in 10 vol. ice-cold (0-4 °C) medium containing 50 mM Tris (hydroxymethyl) aminomethane-HCl (Tris-HCl), pH 7.4 and 300 mM sucrose using an ice-chilled glass ho mogenizing vessel at 900 rpm (4-5 strokes). Then, the homogenate was centrifuged at l,000xg for 10 min to remove nuclei and debris. In the result ing supernatant the protein content was deter mined according to Lowry et al. (1951) and then AChE activities were measured. The enzyme incu bation mixture was kept at 37 °C.
Preincubation o f G A L and its derivatives
Various concentrations (1-16 mM) of Gal (Sigma), Gal-l-P (Sigma), and Galtol (Sigma) were preincubated with 100 (ig protein of whole brain homogenates or with 0.1 ^ig protein of eel Electroforus electricus pure AChE (Sigma) for lh and then AChE activities were measured. The pre incubation medium (about 1 ml) contained 50 mM Tris-HCl, pH 8.0 and 240 mM sucrose in the pres ence of 120 mM NaCl. For comparison, glucose (Glu) (Sigma) as well as glucose-l-phosphate (Glu-l-P) (Sigma) were also tested as above.
Determination o f A C h E activity
AChE activity was determined according to the method of Ellman et al. (1961) . The reaction mix ture (1 ml) contained 50 mM Tris-HCl, pH 8.0 and 240 mM sucrose in the presence of 120 mM NaCl. Protein concentration was 80-100 [ig/ml incuba tion mixture for the homogenised brain and 0.1 (ig/ ml for the eel E.electricus pure AChE. Then, 0.030 ml of 5.5'-dithionitrobenzoic acid (DTNB) and 0.050 ml of acetylthiocholine iodide, used as a substrate, were added and the reaction was started. The final concentrations of DTNB and substrate were 0.125 and 0.5 mM, respectively. The reaction was followed spectrophotometrically by absorbance (AOD) at 412 nm.
Statistical analysis
The data were analyzed by using two-tailed Stu dent's r-test. A p value of < 0.05 was considered statistically significant.
Results and Discussion
The effect of various concentrations (1-16 mM) Galtol as well as Gal-l-P on brain AChE activity are presented in Figure 1 . AChE activity was markedly increased (about 25%, p<0.001), when the brain homogenate was incubated with the usu ally found concentrations (up to 2 m M ) of the Gal tol in the untreated galactosemic patients. There after, the enzyme activity was decreased reaching the control value, when incubated with high con centrations (4-16 m M ) . Galtol modulated E. electricus pure AChE activity (non-membrane bound enzyme) in the same way.
Furthermore, incubation of brain homogenate with 1 mM of Gal-l-P resulted in 10% (p<0.05) inGalactose-1-phosphate or Galactitol (mM) Fig. 1 . Effects of different concentrations of Galactitol (G a lto l---) or galactose-l-phosphate (Gal-l-P-----) on AChE activity. Galtol was preincubated for lh with rat brain homogenates (•) or E. electricus pure AChE (o). Gal-l-P was preincubated for lh with rat brain ho mogenates (■) or E.electricus pure AChE (□). Control value of brain AChE activity was 0.960 ±0.040 AOD/min hibition of AChE. Concentrations of the ester (2 m M or 4 m M ) usually found in patients with clas sical galactosemia (Segal, 1995) resulted in re duced enzyme activity 15% (p<0.01) and 22% (p<0.01) respectively, reaching a plateau of inhibi tion 38% (p<0.001) when 8-16 mM of Gal-l-P was added in the incubation mixture. Additionally, pure E.electricus AChE was inhibited in the same way when incubated with the same concentrations.
Interestingly, when 2 m M of Galtol and Gal-l-P were added in the incubation medium simulta neously, brain AChE activity increased 16% (p<0.01). However, high concentrations (16 mM) of the substances in the incubation mixture re sulted in a 35% (pcO.OOl) inhibition of the en zyme. Neither Gal, Glu nor Glu-l-P all tested over the range of 1-16 m M , had any statistically signifi cant effect on brain AChE activity (p>0.05).
Gal-l-P inhibitor effect (figure) seems to repre sent a different type of interaction than a simple phosphorylation of AChE, since Glu-l-P did not cause any measurable action. Thus, the observed statistically significant influence of AChE by Gall-P vs Glu-l-P could be the result of a different configuration induced by Gal and Glu. Gal as an epimer of Glu at C-4 differs in configuration only at one asymmetric center (Segal, 1995) . In con trast, Galtol stimulated brain AChE as well as E.electricus pure AChE. This Gal derivative might produce an enzyme stimulation by changing the configurating the AChE molecule. Galtol, as a polyol might loose its protons, acquiring negative charges. AChE stimulation might also be due to the interaction of these negative charges with NH4+ terminals of AChE. Interestingly, as it was found, the simultaneous addition of each sub stance (Galtol, Gal-l-P) in the brain homogenate caused an AChE stimulation which can affect ACh degradation in patients with untreated galac tosemia. Since the two molecules are derivatives of the same biochemical pathway, their simulta neous existence in the synaptic microenvironment is likely. The fact that these two molecules exert opposite actions on the activity of AChE may indi cate that this pair of molecules has a regulatory effect on the activity of the enzyme when present at normal concentrations and at the correct molar ratio. If these conditions are not met, these mole cules alter the enzyme activity, either positively or negatively, possibly depending on the molecular ratios. Therefore, in the case of the simultaneous brain accumulation of these compounds, as it is presented in the untreated patients with classical galactosemia, cholinergic dysfunction of their central nervous system, especially in infants with developing brain, might be observed (Schulpis e tal., 1997) .
Galtol as well as Gal-l-P modulated brain AChE activity in the same way as pure E.electricus AChE (Fig. 1) . AChE is an ectoenzyme of brain synaptic membranes. Consequently, these com pounds do not influence the enzyme indirectly but they act on AChE molecule directly. This direct action of Galtol and Gal-l-P on AChE molecule might explain the mechanism of impairment of cholinergic functions of the brain of patients with galactose metabolic disorders.
